FAQ: What is CAR T-cell therapy?

CAR T-cell therapy is an innovative and personalized form of immunotherapy used to treat certain types of cancer. It involves an advanced process of genetic engineering, where a patient’s own T-cells are extracted and modified in the laboratory to express chimeric antigen receptors (CARs) on their surface. These CARs are designed to target specific antigens present on cancer cells. Once the CAR T-cells are infused back into the patient, they can recognize and attack cancer cells with the matching antigens. CAR T-cell therapy has shown remarkable success in treating certain blood cancers, and ongoing research aims to extend its application to other types of cancer as well.